Daniel M. Muyey

Taiyuan, 030001, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Synergy Between second-generation FLT3 inhibitors and the ERK1/2 inhibitor Ulixertinib in FLT3-ITD-mutated acute myeloid leukemia (AML) cells.

Synergy Between second-generation FLT3 inhibitors and the ERK1/2 inhibitor Ulixertinib in FLT3-ITD-mutated acute myeloid leukemia (AML) cells.

Journal: Medical oncology (Northwood, London, England)
Published: June 03, 2025

Baicalein attenuates oxidative damage in mice haematopoietic cells through regulation of PDGFRβ.

Baicalein attenuates oxidative damage in mice haematopoietic cells through regulation of PDGFRβ.

Journal: Molecular and cellular probes
Published: January 20, 2024

A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia.

A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia.

Journal: Frontiers in oncology
Published: July 21, 2023

NRASmutDNMT3Amut Clone Identifies a Subset of de novo Cytogenetically Normal Acute Myeloid Leukemia with Adverse Prognosis.

NRASmutDNMT3Amut Clone Identifies a Subset of de novo Cytogenetically Normal Acute Myeloid Leukemia with Adverse Prognosis.

Journal: Annals of clinical and laboratory science
Published: July 12, 2023

A new pathway for the transformation of AML in MDS: APA mechanism regulated by NUDT21 and RUNX1.

A new pathway for the transformation of AML in MDS: APA mechanism regulated by NUDT21 and RUNX1.

Journal: Neoplasma
Published: January 15, 2023

The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia.

The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia.

Journal: Cancer medicine
Published: October 09, 2022

The characteristics and clinical prognosis analysis of ASXL1 mutations in Chinese adult patients with primary cytogenetically normal acute myeloid leukemia by next-generation sequencing.

The characteristics and clinical prognosis analysis of ASXL1 mutations in Chinese adult patients with primary cytogenetically normal acute myeloid leukemia by next-generation sequencing.

Journal: Leukemia & lymphoma
Published: June 02, 2022

BCR/ABL1ΔE7-8-9 isoform contributes to tyrosine kinase inhibitor resistance in chronic myeloid leukemia.

BCR/ABL1ΔE7-8-9 isoform contributes to tyrosine kinase inhibitor resistance in chronic myeloid leukemia.

Journal: Hematological oncology
Published: January 25, 2022

The clinical characteristics and prognosis of Chinese acute myeloid leukemia patients with CSF3R mutations.

The clinical characteristics and prognosis of Chinese acute myeloid leukemia patients with CSF3R mutations.

Journal: International journal of laboratory hematology
Published: July 11, 2021

The clinical characteristics and prognosis of cytogenetically normal AML with single mutations of CEBPA.

The clinical characteristics and prognosis of cytogenetically normal AML with single mutations of CEBPA.

Journal: International journal of laboratory hematology
Published: February 19, 2021

GATA2 rs2335052 and GATA2 rs78245253 single-nucleotide polymorphisms in Chinese patients with acute myelocytic leukemia.

GATA2 rs2335052 and GATA2 rs78245253 single-nucleotide polymorphisms in Chinese patients with acute myelocytic leukemia.

Journal: International journal of laboratory hematology
Published: January 21, 2021
Showing 1-11 of 11

Last Updated: 09/26/2026